These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19997578)

  • 1. Vascular health in children and adolescents: effects of obesity and diabetes.
    Short KR; Blackett PR; Gardner AW; Copeland KC
    Vasc Health Risk Manag; 2009; 5():973-90. PubMed ID: 19997578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease in childhood: the role of obesity.
    Herouvi D; Karanasios E; Karayianni C; Karavanaki K
    Eur J Pediatr; 2013 Jun; 172(6):721-32. PubMed ID: 23340698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular and Endothelial Function in Youth with Type 2 Diabetes Mellitus.
    Shah AS; Urbina EM
    Curr Diab Rep; 2017 Jun; 17(6):36. PubMed ID: 28432570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 6. Endothelial dysfunction and arterial abnormalities in childhood obesity.
    Skilton MR; Celermajer DS
    Int J Obes (Lond); 2006 Jul; 30(7):1041-9. PubMed ID: 16801941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive measurement of carotid extra-media thickness: associations with cardiovascular risk factors and intima-media thickness.
    Skilton MR; Sérusclat A; Sethu AH; Brun S; Bernard S; Balkau B; Moulin P; Bonnet F
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):176-82. PubMed ID: 19356553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A primary care register for impaired glucose handling (IGH): impact on cardiometabolic profile.
    Heald AH; Knapman H; Nair S; Chambers T; Radford D; Rushton T; Anderson SG
    Prim Care Diabetes; 2012 Oct; 6(3):213-9. PubMed ID: 22560663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arterial compliance in obese children: implications for cardiovascular health.
    Tryggestad JB; Short KR
    Exerc Sport Sci Rev; 2014 Oct; 42(4):175-82. PubMed ID: 25062003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular manifestations of insulin resistance.
    Chahwala V; Arora R
    Am J Ther; 2009; 16(5):e14-28. PubMed ID: 19114874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction and its role in diabetic vascular disease.
    Hartge MM; Kintscher U; Unger T
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):551-60, viii-ix. PubMed ID: 16959585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Youth with obesity and obesity-related type 2 diabetes mellitus demonstrate abnormalities in carotid structure and function.
    Urbina EM; Kimball TR; McCoy CE; Khoury PR; Daniels SR; Dolan LM
    Circulation; 2009 Jun; 119(22):2913-9. PubMed ID: 19470890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Habitual exercise and arterial aging.
    Seals DR; Desouza CA; Donato AJ; Tanaka H
    J Appl Physiol (1985); 2008 Oct; 105(4):1323-32. PubMed ID: 18583377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The endothelium and vascular inflammation in diabetes.
    Hartge MM; Unger T; Kintscher U
    Diab Vasc Dis Res; 2007 Jun; 4(2):84-8. PubMed ID: 17654441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of cardiovascular disease in type 2 diabetic patients].
    Yokota C
    Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
    Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB
    Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549
    [No Abstract]   [Full Text] [Related]  

  • 17. Optimal diabetes management during medical weight loss for cardiovascular risk reduction.
    Nori Janosz KE; Miller WM; Odom J; Lillystone M; McCullough PA
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):761-75. PubMed ID: 16076284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome.
    Hadi HA; Carr CS; Al Suwaidi J
    Vasc Health Risk Manag; 2005; 1(3):183-98. PubMed ID: 17319104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing cardiovascular disease risk in patients with diabetes: a message from the National Diabetes Education Program.
    Blonde L; Dempster J; Gallivan JM; Warren-Boulton E
    J Am Acad Nurse Pract; 2006 Nov; 18(11):524-33. PubMed ID: 17064330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.